We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Trumpf Medizin Systeme

Develops and produces solutions and products to improve efficiency, safety, and patient care in the operating room an... read more Featured Products: More products

Download Mobile App




Hill-Rom Holdings to Acquire TRUMPF Medical

By HospiMedica International staff writers
Posted on 29 Jun 2014
Hill-Rom Holdings (Batesville, IN, USA), a leading manufacturer and provider of medical technologies and related services for the healthcare industry, has signed a definitive agreement to purchase TRUMPF Medical Systems (Saalfeld, Germany), for approximately USD 250 million in cash. More...


TRUMPF Medical, the medical unit of the privately held TRUMPF Group (Ditzingen, Germany), a manufacturer of machine tool and laser systems, holds a portfolio of well-established operating room (OR) infrastructure products such as surgical tables, surgical lighting, and supply units. The addition of the TRUMPF line of integrated OR solutions will double Hill-Rom's surgical portfolio, which includes Bard-Parker scalpels, the Allen Advance Spine Table, patient positioning accessories, surgical supplies, and surgical fluids management systems.

The acquisition of the medical technology division of TRUMPF Medical includes the two German factories situated in Saalfeld (Thuringia, Germany) and Puchheim (Bavaria, Germany) and its foreign subsidiaries, and also includes existing sales channels and customer relationships. The acquisition will also strengthen Hill-Rom's geographic footprint in high-growth markets, including Asia/Pacific, the Middle East, Eastern Europe, and Latin America.

“The acquisition of TRUMPF Medical reflects our focused and disciplined strategy to pursue acquisitions that capitalize on Hill-Rom's brand equity in targeted areas, diversify our portfolio and meet our objectives for growth and value creation,” said John J. Greisch, president and CEO of Hill-Rom. “The TRUMPF Medical business expands our portfolio beyond patient handling and mobility with innovative solutions for the operating room, and diversifies our revenue stream with a sizable international surgical platform that will allow us to capitalize on emerging market growth.”

“With Hill-Rom, our Medical technology division has better growth opportunities than TRUMPF, with production technology as its core competence, can give it,” said Harald Völker, Head of Medical Technology in the TRUMPF Group Management. “The product portfolios of both companies enhance each other perfectly, and in international sales, too, we both cover more international markets than either of us would on their own.”

Related Links:

Hill-Rom Holdings
TRUMPF Medical Systems



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
12-Lead Electrocardiograph
ASPEL ECG GREY v.07.325
New
Portable Digital Floor Scale
DR400C
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A mechanosensing-based approach offers a potential path to the treatment for cardiac fibrosis (Photo courtesy of Adobe Stock)

Mechanosensing-Based Approach Offers Promising Strategy to Treat Cardiovascular Fibrosis

Cardiac fibrosis, which involves the stiffening and scarring of heart tissue, is a fundamental feature of nearly every type of heart disease, from acute ischemic injuries to genetic cardiomyopathies.... Read more

Surgical Techniques

view channel
Image: Bioprinting synthetic vasculature could dramatically change how cardiovascular diseases are treated (Dell, A.C., Maresca, J., Davis, B.A. et al.; doi.org/10.1038/s41598-025-93276-y)

Bioprinted Aortas Offer New Hope for Vascular Repair

Current treatment options for severe cardiovascular diseases include using grafts made from a patient's own tissue (autologous) or synthetic materials. However, autologous grafts require invasive surgery... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.